Srinivas Ramachandran
Concepts (395)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nucleosomes | 17 | 2026 | 168 | 4.560 |
Why?
| | Chromatin | 13 | 2026 | 559 | 4.090 |
Why?
| | Cell-Free Nucleic Acids | 4 | 2026 | 40 | 3.110 |
Why?
| | Histones | 13 | 2026 | 670 | 3.080 |
Why?
| | Chromatin Assembly and Disassembly | 9 | 2026 | 109 | 2.710 |
Why?
| | Mycobacterium tuberculosis | 7 | 2026 | 325 | 1.960 |
Why?
| | Computational Biology | 10 | 2025 | 678 | 1.590 |
Why?
| | Transcription, Genetic | 12 | 2022 | 1432 | 1.450 |
Why?
| | Hydro-Lyases | 2 | 2026 | 7 | 1.420 |
Why?
| | Transcription Factors | 7 | 2022 | 1730 | 1.360 |
Why?
| | Bacterial Proteins | 9 | 2019 | 980 | 1.320 |
Why?
| | Promoter Regions, Genetic | 9 | 2025 | 1242 | 1.260 |
Why?
| | Heterochromatin | 3 | 2026 | 68 | 1.240 |
Why?
| | Antitubercular Agents | 3 | 2026 | 212 | 1.230 |
Why?
| | Software | 7 | 2026 | 676 | 1.180 |
Why?
| | Polycomb Repressive Complex 2 | 2 | 2026 | 79 | 0.970 |
Why?
| | Saccharomycetales | 2 | 2018 | 31 | 0.950 |
Why?
| | Histone Chaperones | 1 | 2025 | 15 | 0.880 |
Why?
| | Saccharomyces cerevisiae Proteins | 4 | 2025 | 411 | 0.870 |
Why?
| | G1 Phase | 1 | 2025 | 64 | 0.870 |
Why?
| | Fungi | 3 | 2017 | 120 | 0.860 |
Why?
| | Enzyme Inhibitors | 3 | 2026 | 823 | 0.840 |
Why?
| | DNA Replication | 2 | 2017 | 248 | 0.840 |
Why?
| | Open Reading Frames | 1 | 2025 | 130 | 0.830 |
Why?
| | Drosophila melanogaster | 4 | 2019 | 237 | 0.790 |
Why?
| | Psoriasis | 1 | 2025 | 110 | 0.790 |
Why?
| | Cell Cycle | 2 | 2024 | 595 | 0.750 |
Why?
| | Telomere | 1 | 2026 | 300 | 0.750 |
Why?
| | DNA | 2 | 2022 | 1421 | 0.730 |
Why?
| | Biological Products | 1 | 2026 | 258 | 0.720 |
Why?
| | Alzheimer Disease | 9 | 2025 | 641 | 0.700 |
Why?
| | Genome, Fungal | 4 | 2017 | 48 | 0.690 |
Why?
| | Protein Binding | 8 | 2025 | 2244 | 0.680 |
Why?
| | Drug Resistance, Bacterial | 1 | 2022 | 185 | 0.660 |
Why?
| | Virulence Factors | 2 | 2014 | 175 | 0.650 |
Why?
| | Epigenomics | 2 | 2020 | 124 | 0.650 |
Why?
| | NF-kappa B | 1 | 2025 | 674 | 0.650 |
Why?
| | Mouse Embryonic Stem Cells | 3 | 2026 | 36 | 0.650 |
Why?
| | Oryza | 3 | 2020 | 34 | 0.640 |
Why?
| | High-Throughput Nucleotide Sequencing | 3 | 2026 | 539 | 0.630 |
Why?
| | Gene Expression Regulation | 5 | 2025 | 2599 | 0.630 |
Why?
| | Databases, Genetic | 4 | 2025 | 239 | 0.630 |
Why?
| | Saccharomyces cerevisiae | 5 | 2026 | 584 | 0.630 |
Why?
| | DNA Methylation | 3 | 2022 | 725 | 0.620 |
Why?
| | Anti-Infective Agents | 1 | 2022 | 234 | 0.600 |
Why?
| | Enhancer Elements, Genetic | 1 | 2021 | 190 | 0.600 |
Why?
| | Fungal Vaccines | 2 | 2017 | 2 | 0.590 |
Why?
| | RNA Polymerase II | 6 | 2022 | 347 | 0.580 |
Why?
| | Archaeal Proteins | 4 | 2007 | 50 | 0.550 |
Why?
| | Molecular Docking Simulation | 6 | 2026 | 121 | 0.540 |
Why?
| | Deoxyuridine | 1 | 2018 | 6 | 0.540 |
Why?
| | Lipid Bilayers | 4 | 2016 | 105 | 0.530 |
Why?
| | User-Computer Interface | 4 | 2025 | 168 | 0.530 |
Why?
| | Protozoan Proteins | 2 | 2008 | 88 | 0.520 |
Why?
| | Molecular Dynamics Simulation | 10 | 2026 | 267 | 0.520 |
Why?
| | Gene Regulatory Networks | 2 | 2025 | 319 | 0.510 |
Why?
| | Binding Sites | 8 | 2025 | 1309 | 0.490 |
Why?
| | Gene Expression Profiling | 9 | 2022 | 1792 | 0.490 |
Why?
| | Animals | 24 | 2026 | 38107 | 0.480 |
Why?
| | Bridged-Ring Compounds | 1 | 2016 | 31 | 0.480 |
Why?
| | Algorithms | 6 | 2015 | 1849 | 0.470 |
Why?
| | Mycoses | 1 | 2017 | 87 | 0.470 |
Why?
| | S Phase | 1 | 2016 | 77 | 0.460 |
Why?
| | Ketones | 1 | 2016 | 51 | 0.460 |
Why?
| | Data Mining | 2 | 2021 | 113 | 0.460 |
Why?
| | Dinucleotide Repeats | 2 | 2007 | 6 | 0.460 |
Why?
| | Epigenesis, Genetic | 2 | 2020 | 712 | 0.460 |
Why?
| | Methylation | 3 | 2025 | 241 | 0.450 |
Why?
| | PubMed | 1 | 2015 | 15 | 0.450 |
Why?
| | Search Engine | 1 | 2015 | 13 | 0.450 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 2006 | 116 | 0.450 |
Why?
| | Fomites | 1 | 2015 | 6 | 0.450 |
Why?
| | Drug Resistance, Microbial | 1 | 2015 | 67 | 0.440 |
Why?
| | Mutation | 7 | 2025 | 4093 | 0.430 |
Why?
| | Amyloid beta-Peptides | 5 | 2016 | 251 | 0.410 |
Why?
| | Micrococcal Nuclease | 3 | 2021 | 26 | 0.400 |
Why?
| | Humans | 51 | 2026 | 146342 | 0.400 |
Why?
| | Metagenomics | 1 | 2015 | 154 | 0.400 |
Why?
| | Connexin 43 | 1 | 2014 | 37 | 0.400 |
Why?
| | Sequence Analysis, Protein | 2 | 2004 | 32 | 0.400 |
Why?
| | Superoxide Dismutase-1 | 3 | 2018 | 13 | 0.390 |
Why?
| | Gap Junctions | 1 | 2014 | 68 | 0.390 |
Why?
| | Sequence Analysis, DNA | 5 | 2026 | 771 | 0.380 |
Why?
| | Plasmodium | 2 | 2014 | 12 | 0.370 |
Why?
| | Adhesins, Bacterial | 3 | 2014 | 46 | 0.370 |
Why?
| | Drug Evaluation, Preclinical | 2 | 2026 | 195 | 0.360 |
Why?
| | Phenotype | 2 | 2020 | 3206 | 0.360 |
Why?
| | Amyotrophic Lateral Sclerosis | 3 | 2018 | 98 | 0.360 |
Why?
| | Acyltransferases | 1 | 2012 | 78 | 0.360 |
Why?
| | Workflow | 2 | 2025 | 182 | 0.360 |
Why?
| | Malaria | 2 | 2014 | 73 | 0.350 |
Why?
| | Antigens, Bacterial | 1 | 2012 | 125 | 0.340 |
Why?
| | Gene Expression Regulation, Fungal | 2 | 2025 | 79 | 0.330 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2013 | 340 | 0.330 |
Why?
| | Gene Expression | 3 | 2020 | 1463 | 0.330 |
Why?
| | Breast Neoplasms | 3 | 2025 | 2418 | 0.330 |
Why?
| | Databases, Protein | 1 | 2011 | 88 | 0.320 |
Why?
| | Proteomics | 2 | 2011 | 1203 | 0.320 |
Why?
| | Fungal Proteins | 1 | 2011 | 137 | 0.320 |
Why?
| | Genome, Human | 4 | 2007 | 431 | 0.310 |
Why?
| | Peptide Fragments | 5 | 2016 | 693 | 0.310 |
Why?
| | Proteome | 2 | 2006 | 520 | 0.310 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2025 | 2623 | 0.310 |
Why?
| | Amyloid beta-Protein Precursor | 2 | 2025 | 64 | 0.310 |
Why?
| | Estrogen Receptor alpha | 2 | 2025 | 154 | 0.300 |
Why?
| | Biomarkers | 1 | 2020 | 4340 | 0.280 |
Why?
| | Malaria Vaccines | 1 | 2008 | 11 | 0.280 |
Why?
| | Genomics | 3 | 2018 | 853 | 0.280 |
Why?
| | Lysine | 2 | 2025 | 303 | 0.280 |
Why?
| | Hydrogen Bonding | 4 | 2018 | 170 | 0.270 |
Why?
| | Multigene Family | 2 | 2006 | 210 | 0.270 |
Why?
| | Epilepsy | 2 | 2025 | 400 | 0.270 |
Why?
| | Polycomb-Group Proteins | 2 | 2026 | 36 | 0.260 |
Why?
| | Microbiota | 1 | 2015 | 725 | 0.260 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2020 | 139 | 0.260 |
Why?
| | Base Sequence | 5 | 2026 | 2123 | 0.260 |
Why?
| | Base Composition | 2 | 2006 | 81 | 0.260 |
Why?
| | Genetic Predisposition to Disease | 3 | 2025 | 2488 | 0.250 |
Why?
| | Cell Differentiation | 2 | 2025 | 1982 | 0.250 |
Why?
| | Dyskeratosis Congenita | 1 | 2026 | 11 | 0.240 |
Why?
| | Prokaryotic Cells | 1 | 2006 | 6 | 0.240 |
Why?
| | Polymorphism, Genetic | 2 | 2006 | 612 | 0.240 |
Why?
| | Rotation | 1 | 2026 | 124 | 0.240 |
Why?
| | Introns | 1 | 2007 | 257 | 0.240 |
Why?
| | Drosophila | 3 | 2021 | 168 | 0.230 |
Why?
| | Metadata | 1 | 2026 | 17 | 0.230 |
Why?
| | Cyclins | 1 | 2006 | 77 | 0.230 |
Why?
| | Genome, Plant | 3 | 2011 | 37 | 0.230 |
Why?
| | Evolution, Molecular | 2 | 2018 | 502 | 0.220 |
Why?
| | Databases, Factual | 2 | 2026 | 1493 | 0.220 |
Why?
| | Presenilin-2 | 1 | 2025 | 6 | 0.220 |
Why?
| | Cell Line | 3 | 2021 | 2814 | 0.220 |
Why?
| | Fluorescent Dyes | 2 | 2019 | 340 | 0.220 |
Why?
| | Structure-Activity Relationship | 5 | 2018 | 563 | 0.220 |
Why?
| | Presenilin-1 | 1 | 2025 | 34 | 0.220 |
Why?
| | Protein Domains | 2 | 2024 | 315 | 0.210 |
Why?
| | India | 4 | 2025 | 213 | 0.210 |
Why?
| | HEK293 Cells | 2 | 2025 | 750 | 0.210 |
Why?
| | Sequence Alignment | 2 | 2004 | 360 | 0.210 |
Why?
| | Germ Cells | 1 | 2024 | 67 | 0.210 |
Why?
| | Enhancer of Zeste Homolog 2 Protein | 1 | 2024 | 55 | 0.210 |
Why?
| | Embryonic Stem Cells | 1 | 2025 | 124 | 0.210 |
Why?
| | DNA-Binding Proteins | 4 | 2022 | 1468 | 0.200 |
Why?
| | Protein Conformation | 5 | 2018 | 916 | 0.200 |
Why?
| | Phylogeny | 2 | 2011 | 924 | 0.190 |
Why?
| | Bacteria | 2 | 2022 | 766 | 0.190 |
Why?
| | Models, Biological | 5 | 2018 | 1761 | 0.190 |
Why?
| | Hepatocyte Nuclear Factor 3-alpha | 1 | 2022 | 9 | 0.180 |
Why?
| | Internet | 4 | 2026 | 660 | 0.180 |
Why?
| | Knowledge Bases | 1 | 2022 | 28 | 0.180 |
Why?
| | Gene Duplication | 3 | 2007 | 67 | 0.180 |
Why?
| | Transcriptional Elongation Factors | 1 | 2022 | 40 | 0.180 |
Why?
| | Drug Discovery | 2 | 2013 | 154 | 0.180 |
Why?
| | Methanococcus | 1 | 2002 | 10 | 0.180 |
Why?
| | Mice | 5 | 2026 | 18297 | 0.180 |
Why?
| | Protein Processing, Post-Translational | 1 | 2024 | 487 | 0.170 |
Why?
| | Sorghum | 2 | 2011 | 3 | 0.170 |
Why?
| | Haemophilus influenzae | 1 | 2002 | 67 | 0.170 |
Why?
| | Estradiol | 1 | 2025 | 517 | 0.170 |
Why?
| | Membrane Proteins | 1 | 2007 | 1130 | 0.170 |
Why?
| | Arabs | 1 | 2021 | 9 | 0.170 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2024 | 415 | 0.170 |
Why?
| | Protein Interaction Maps | 1 | 2021 | 54 | 0.160 |
Why?
| | Altitude Sickness | 1 | 2022 | 141 | 0.160 |
Why?
| | Amyloid | 4 | 2016 | 90 | 0.160 |
Why?
| | Cyclin-Dependent Kinase 9 | 1 | 2020 | 17 | 0.160 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2023 | 269 | 0.160 |
Why?
| | Models, Molecular | 5 | 2018 | 1574 | 0.160 |
Why?
| | Histone Demethylases | 1 | 2020 | 39 | 0.160 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2020 | 974 | 0.160 |
Why?
| | Peptide Synthases | 1 | 2019 | 4 | 0.150 |
Why?
| | Receptors, Estrogen | 1 | 2022 | 406 | 0.150 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2020 | 163 | 0.140 |
Why?
| | Microscopy, Atomic Force | 3 | 2016 | 126 | 0.140 |
Why?
| | Transcriptional Activation | 1 | 2021 | 369 | 0.140 |
Why?
| | Alleles | 2 | 2021 | 907 | 0.140 |
Why?
| | Plasmodium yoelii | 2 | 2008 | 7 | 0.140 |
Why?
| | Genome | 1 | 2021 | 307 | 0.140 |
Why?
| | Biomarkers, Tumor | 1 | 2026 | 1339 | 0.140 |
Why?
| | Plasmodium vivax | 2 | 2008 | 6 | 0.140 |
Why?
| | Small Molecule Libraries | 1 | 2019 | 113 | 0.140 |
Why?
| | Biosensing Techniques | 1 | 2020 | 143 | 0.140 |
Why?
| | Plasmodium falciparum | 2 | 2008 | 37 | 0.140 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 3 | 2018 | 194 | 0.140 |
Why?
| | Chromosome Mapping | 3 | 2011 | 508 | 0.130 |
Why?
| | Transcription Initiation Site | 1 | 2017 | 43 | 0.130 |
Why?
| | TATA-Box Binding Protein | 1 | 2017 | 19 | 0.130 |
Why?
| | Quantitative Trait Loci | 1 | 2020 | 388 | 0.130 |
Why?
| | Amino Acid Sequence | 5 | 2016 | 2092 | 0.130 |
Why?
| | Genome-Wide Association Study | 1 | 2025 | 1537 | 0.130 |
Why?
| | Oligopeptides | 1 | 2019 | 264 | 0.130 |
Why?
| | Pharmaceutical Preparations | 1 | 2019 | 172 | 0.130 |
Why?
| | Click Chemistry | 1 | 2018 | 54 | 0.130 |
Why?
| | Genetic Variation | 3 | 2021 | 996 | 0.130 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 2017 | 20 | 0.120 |
Why?
| | Microscopy, Fluorescence | 2 | 2019 | 404 | 0.120 |
Why?
| | Antigens, Fungal | 1 | 2017 | 28 | 0.120 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 365 | 0.120 |
Why?
| | Glioblastoma | 1 | 2020 | 350 | 0.120 |
Why?
| | Inhibitory Concentration 50 | 1 | 2016 | 90 | 0.120 |
Why?
| | Eukaryota | 1 | 2017 | 56 | 0.120 |
Why?
| | Pyruvic Acid | 1 | 2016 | 51 | 0.120 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2022 | 1432 | 0.120 |
Why?
| | Aspartic Acid | 1 | 2016 | 88 | 0.120 |
Why?
| | Disease Management | 1 | 2020 | 651 | 0.120 |
Why?
| | SELEX Aptamer Technique | 1 | 2016 | 16 | 0.120 |
Why?
| | Gene Expression Regulation, Plant | 3 | 2020 | 54 | 0.120 |
Why?
| | Medical Subject Headings | 1 | 2015 | 3 | 0.120 |
Why?
| | Tuberculosis | 1 | 2019 | 290 | 0.110 |
Why?
| | Neoplasms | 2 | 2026 | 2954 | 0.110 |
Why?
| | Response Elements | 1 | 2016 | 85 | 0.110 |
Why?
| | Drosophila Proteins | 1 | 2017 | 207 | 0.110 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2017 | 175 | 0.110 |
Why?
| | Catalytic Domain | 1 | 2016 | 235 | 0.110 |
Why?
| | Phenylalanine | 1 | 2015 | 69 | 0.110 |
Why?
| | Trichophyton | 1 | 2015 | 1 | 0.110 |
Why?
| | Onychomycosis | 1 | 2015 | 3 | 0.110 |
Why?
| | Ion Channels | 1 | 2016 | 128 | 0.110 |
Why?
| | Trans-Activators | 1 | 2017 | 372 | 0.110 |
Why?
| | Aptamers, Nucleotide | 1 | 2016 | 88 | 0.110 |
Why?
| | tau Proteins | 1 | 2016 | 111 | 0.110 |
Why?
| | Crystallography, X-Ray | 1 | 2016 | 477 | 0.110 |
Why?
| | Enzyme Activation | 1 | 2016 | 759 | 0.110 |
Why?
| | Prognosis | 2 | 2020 | 4351 | 0.110 |
Why?
| | Genome, Archaeal | 2 | 2006 | 12 | 0.100 |
Why?
| | Recombinant Proteins | 2 | 2016 | 1361 | 0.100 |
Why?
| | Metabolomics | 1 | 2020 | 738 | 0.100 |
Why?
| | Isoquinolines | 1 | 2014 | 44 | 0.100 |
Why?
| | Microtubules | 1 | 2016 | 226 | 0.100 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2007 | 752 | 0.100 |
Why?
| | DNA, Fungal | 1 | 2014 | 76 | 0.100 |
Why?
| | Porosity | 1 | 2014 | 95 | 0.100 |
Why?
| | Antibiotics, Antitubercular | 1 | 2013 | 35 | 0.100 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2014 | 60 | 0.100 |
Why?
| | Allergens | 1 | 2017 | 390 | 0.100 |
Why?
| | Centromere | 1 | 2014 | 62 | 0.100 |
Why?
| | Permeability | 1 | 2014 | 166 | 0.100 |
Why?
| | Carrier Proteins | 1 | 2017 | 728 | 0.100 |
Why?
| | Genome, Bacterial | 2 | 2006 | 122 | 0.100 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2025 | 2240 | 0.100 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2014 | 131 | 0.100 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2004 | 382 | 0.090 |
Why?
| | Kinetics | 1 | 2016 | 1553 | 0.090 |
Why?
| | Sequence Deletion | 1 | 2013 | 190 | 0.090 |
Why?
| | MicroRNAs | 1 | 2019 | 699 | 0.090 |
Why?
| | Biological Transport | 1 | 2014 | 424 | 0.090 |
Why?
| | Metabolic Networks and Pathways | 1 | 2013 | 175 | 0.090 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 335 | 0.090 |
Why?
| | Female | 8 | 2026 | 79499 | 0.090 |
Why?
| | Cluster Analysis | 1 | 2013 | 496 | 0.090 |
Why?
| | Edible Grain | 1 | 2011 | 45 | 0.090 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1942 | 0.080 |
Why?
| | Drug Design | 1 | 2012 | 180 | 0.080 |
Why?
| | Signal Transduction | 1 | 2025 | 5246 | 0.080 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2011 | 43 | 0.080 |
Why?
| | Reproducibility of Results | 3 | 2018 | 3416 | 0.080 |
Why?
| | Phosphorylation | 3 | 2022 | 1724 | 0.080 |
Why?
| | Protein Structure, Secondary | 3 | 2018 | 357 | 0.080 |
Why?
| | Brain Neoplasms | 1 | 2020 | 1325 | 0.080 |
Why?
| | Host-Pathogen Interactions | 1 | 2014 | 366 | 0.080 |
Why?
| | Comorbidity | 1 | 2015 | 1665 | 0.080 |
Why?
| | Molecular Sequence Data | 4 | 2015 | 2838 | 0.080 |
Why?
| | Calcium | 2 | 2014 | 1181 | 0.080 |
Why?
| | Ligands | 1 | 2012 | 678 | 0.080 |
Why?
| | Cells, Cultured | 1 | 2017 | 4118 | 0.080 |
Why?
| | Genotype | 3 | 2025 | 1879 | 0.070 |
Why?
| | Computer Simulation | 1 | 2013 | 1014 | 0.070 |
Why?
| | ROC Curve | 1 | 2011 | 617 | 0.070 |
Why?
| | Rats | 2 | 2016 | 5586 | 0.070 |
Why?
| | Amino Acids | 2 | 2018 | 515 | 0.070 |
Why?
| | Fibroblasts | 1 | 2014 | 1034 | 0.070 |
Why?
| | Archaeoglobus fulgidus | 1 | 2007 | 1 | 0.070 |
Why?
| | Mycobacterium leprae | 1 | 2007 | 9 | 0.070 |
Why?
| | Antigens, Surface | 1 | 2008 | 155 | 0.070 |
Why?
| | Protein Structure, Tertiary | 2 | 2010 | 834 | 0.070 |
Why?
| | Escherichia coli K12 | 1 | 2007 | 7 | 0.070 |
Why?
| | Mycobacterium bovis | 1 | 2007 | 15 | 0.060 |
Why?
| | Expressed Sequence Tags | 1 | 2007 | 43 | 0.060 |
Why?
| | Protein Array Analysis | 1 | 2007 | 56 | 0.060 |
Why?
| | Bacillus subtilis | 1 | 2007 | 67 | 0.060 |
Why?
| | DNA Primers | 1 | 2007 | 487 | 0.060 |
Why?
| | Diabetes Mellitus | 1 | 2015 | 1101 | 0.060 |
Why?
| | Base Pairing | 1 | 2006 | 65 | 0.060 |
Why?
| | Microsatellite Repeats | 1 | 2007 | 159 | 0.060 |
Why?
| | Disasters | 1 | 2007 | 101 | 0.060 |
Why?
| | Chromosomes, Artificial, Bacterial | 1 | 2006 | 22 | 0.060 |
Why?
| | DNA Copy Number Variations | 2 | 2020 | 192 | 0.060 |
Why?
| | Genetic Markers | 2 | 2020 | 340 | 0.060 |
Why?
| | Male | 5 | 2026 | 73396 | 0.060 |
Why?
| | Ribosomes | 1 | 2007 | 196 | 0.060 |
Why?
| | Single Molecule Imaging | 1 | 2026 | 48 | 0.060 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2026 | 65 | 0.060 |
Why?
| | Escherichia coli Proteins | 1 | 2007 | 200 | 0.060 |
Why?
| | Pan troglodytes | 1 | 2005 | 62 | 0.050 |
Why?
| | Arabidopsis Proteins | 1 | 2006 | 78 | 0.050 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2026 | 147 | 0.050 |
Why?
| | STAT1 Transcription Factor | 1 | 2025 | 68 | 0.050 |
Why?
| | Neurons | 2 | 2025 | 1668 | 0.050 |
Why?
| | MCF-7 Cells | 1 | 2025 | 133 | 0.050 |
Why?
| | Glycolysis | 1 | 2006 | 342 | 0.050 |
Why?
| | CD28 Antigens | 1 | 2024 | 57 | 0.050 |
Why?
| | Models, Genetic | 1 | 2007 | 540 | 0.050 |
Why?
| | Models, Theoretical | 1 | 2008 | 561 | 0.050 |
Why?
| | Twins, Monozygotic | 1 | 2005 | 133 | 0.050 |
Why?
| | Adult | 2 | 2026 | 41087 | 0.050 |
Why?
| | Databases, Nucleic Acid | 1 | 2003 | 39 | 0.050 |
Why?
| | Models, Statistical | 2 | 2005 | 669 | 0.050 |
Why?
| | Models, Chemical | 1 | 2004 | 252 | 0.050 |
Why?
| | Down Syndrome | 1 | 2010 | 529 | 0.050 |
Why?
| | Campylobacter jejuni | 1 | 2003 | 16 | 0.050 |
Why?
| | Vibrio cholerae | 1 | 2003 | 14 | 0.050 |
Why?
| | Strongyloides stercoralis | 1 | 2002 | 2 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2004 | 391 | 0.050 |
Why?
| | Antigens, Helminth | 1 | 2002 | 16 | 0.050 |
Why?
| | Strongyloidiasis | 1 | 2002 | 4 | 0.050 |
Why?
| | Peptide Elongation Factors | 1 | 2022 | 15 | 0.050 |
Why?
| | Helicobacter pylori | 1 | 2003 | 44 | 0.050 |
Why?
| | Erythropoiesis | 1 | 2022 | 57 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 3545 | 0.040 |
Why?
| | Familial Mediterranean Fever | 1 | 2021 | 7 | 0.040 |
Why?
| | Hemoglobinopathies | 1 | 2021 | 6 | 0.040 |
Why?
| | Risk Factors | 1 | 2015 | 10921 | 0.040 |
Why?
| | Protease Inhibitors | 1 | 2021 | 103 | 0.040 |
Why?
| | Epilepsy, Absence | 1 | 2020 | 12 | 0.040 |
Why?
| | Age of Onset | 1 | 2022 | 558 | 0.040 |
Why?
| | Epilepsy, Generalized | 1 | 2020 | 24 | 0.040 |
Why?
| | Positive Transcriptional Elongation Factor B | 1 | 2020 | 28 | 0.040 |
Why?
| | Gibberellins | 1 | 2020 | 1 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2015 | 11821 | 0.040 |
Why?
| | Pharmacogenomic Testing | 1 | 2020 | 63 | 0.040 |
Why?
| | Plant Breeding | 1 | 2020 | 21 | 0.040 |
Why?
| | Gene Frequency | 1 | 2021 | 496 | 0.040 |
Why?
| | Plant Proteins | 1 | 2020 | 110 | 0.040 |
Why?
| | Molecular Conformation | 1 | 2019 | 141 | 0.040 |
Why?
| | Color | 1 | 2019 | 80 | 0.040 |
Why?
| | Drug Repositioning | 1 | 2019 | 41 | 0.040 |
Why?
| | Fluorescence | 1 | 2019 | 160 | 0.040 |
Why?
| | Enzyme Stability | 1 | 2018 | 74 | 0.030 |
Why?
| | Escherichia coli | 1 | 2003 | 832 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2019 | 297 | 0.030 |
Why?
| | Autoimmunity | 1 | 2024 | 925 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2019 | 201 | 0.030 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2022 | 530 | 0.030 |
Why?
| | Molecular Structure | 1 | 2019 | 484 | 0.030 |
Why?
| | Genes | 1 | 2018 | 215 | 0.030 |
Why?
| | TATA-Binding Protein Associated Factors | 1 | 2017 | 23 | 0.030 |
Why?
| | Transcription Factor TFIID | 1 | 2017 | 22 | 0.030 |
Why?
| | Conserved Sequence | 1 | 2018 | 242 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2020 | 627 | 0.030 |
Why?
| | RNA, Fungal | 1 | 2017 | 71 | 0.030 |
Why?
| | Protein Subunits | 1 | 2017 | 225 | 0.030 |
Why?
| | Inverted Repeat Sequences | 1 | 2016 | 18 | 0.030 |
Why?
| | Seizures | 1 | 2020 | 489 | 0.030 |
Why?
| | Precision Medicine | 1 | 2020 | 462 | 0.030 |
Why?
| | Regression Analysis | 1 | 2018 | 999 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1827 | 0.030 |
Why?
| | Gene Deletion | 1 | 2017 | 385 | 0.030 |
Why?
| | Dimerization | 1 | 2016 | 174 | 0.030 |
Why?
| | Transcriptome | 1 | 2022 | 1068 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2021 | 779 | 0.030 |
Why?
| | Arthrodermataceae | 1 | 2015 | 2 | 0.030 |
Why?
| | Family Health | 1 | 2015 | 194 | 0.030 |
Why?
| | Hypoxia | 1 | 2022 | 1211 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 1378 | 0.030 |
Why?
| | Cytoplasm | 1 | 2014 | 253 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2024 | 6034 | 0.020 |
Why?
| | Transgenes | 1 | 2014 | 178 | 0.020 |
Why?
| | Estrogens | 1 | 2016 | 364 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2016 | 729 | 0.020 |
Why?
| | Phosphatidylcholines | 1 | 2013 | 131 | 0.020 |
Why?
| | Genetic Testing | 1 | 2015 | 492 | 0.020 |
Why?
| | RNA Interference | 1 | 2014 | 472 | 0.020 |
Why?
| | INDEL Mutation | 1 | 2011 | 21 | 0.020 |
Why?
| | Disease Resistance | 1 | 2011 | 30 | 0.020 |
Why?
| | Breeding | 1 | 2011 | 64 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 2014 | 724 | 0.020 |
Why?
| | Peptides | 1 | 2016 | 992 | 0.020 |
Why?
| | Brain | 1 | 2022 | 2991 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 7109 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2017 | 2791 | 0.020 |
Why?
| | Aged | 2 | 2022 | 26432 | 0.020 |
Why?
| | Middle Aged | 2 | 2025 | 36619 | 0.020 |
Why?
| | Cell Death | 1 | 2010 | 379 | 0.020 |
Why?
| | United States | 1 | 2026 | 16136 | 0.020 |
Why?
| | RNA | 1 | 2014 | 926 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2005 | 269 | 0.010 |
Why?
| | Oligonucleotides | 1 | 2005 | 155 | 0.010 |
Why?
| | Leukocytes | 1 | 2005 | 301 | 0.010 |
Why?
| | Haplotypes | 1 | 2005 | 506 | 0.010 |
Why?
| | Histamine | 1 | 2002 | 52 | 0.010 |
Why?
| | Life Cycle Stages | 1 | 2002 | 38 | 0.010 |
Why?
| | Cross Reactions | 1 | 2002 | 130 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2002 | 526 | 0.010 |
Why?
| | Blotting, Western | 1 | 2002 | 1177 | 0.010 |
Why?
| | Sex Factors | 1 | 2005 | 2107 | 0.010 |
Why?
|
|
Ramachandran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|